Company: GCTS
Filing Date: 2025-05-16
Form Type: 424B5
Source: 0001104659-25-049833
Chunk: 13

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-05-16
Form: 424B5
Chunk 13
---
 assets, our consolidation
or merger with or into another person, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the kind
and amount of securities, cash or other property that the holders would have received had they exercised the Warrants immediately prior
to such fundamental transaction. In addition, in certain circumstances, upon a fundamental transaction, the holder of a Warrant will have
the right to require us to repurchase its Warrants at the Black-Scholes value; provided, however, that, if the fundamental transaction
is not within our control, including not approved by our board of directors, then the holder will only be entitled to receive the same
type or form of consideration (and in the same proportion), at the Black-Scholes value of the unexercised portion of the Warrant that
is being offered and paid to the holders of our Common Stock in connection with the fundamental transaction.

Rights as a Stockholder. Except
as otherwise provided in the Warrants or by virtue of such holder’s ownership of shares of our Common Stock, the holder of a Warrant
does not have the rights or privileges of a holder of our Common Stock, including any voting rights, until the holder exercises the Warrant.

NYSE

Our Common Stock trades on
the New York Stock Exchange under the symbol “GCTS.” On May 14, 2025, the closing price of our Common Stock on the New York
Stock Exchange was $2.20 per share.

Transfer Agent and Registrar

The Transfer Agent and Registrar
for our Common Stock is Continental Stock Transfer and Trust Company with an address at 1 State Street, 30th Floor, New York, NY 10004.

<div align='center'>S-9

PLAN OF DISTRIBUTION</div>

Pursuant to a placement agency
agreement dated May 15, 2025 (the “Placement Agency Agreement”), we have engaged Roth Capital Partners, LLC to act as our
exclusive placement agent in connection with this Offering of our Shares of Common Stock and Warrants pursuant to this prospectus supplement
and accompanying prospectus. Under the terms of the Placement Agency Agreement, the Placement Agent has agreed to be our exclusive placement
agent, on a reasonable best-efforts basis, in connection with the issuance and sale by us of our shares of Common Stock and Warrants in
this Offering from our shelf registration statement. The terms of this Offering were subject to market conditions and negotiations between
us, the Placement Agent and